- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Public Companies
Biglari's revised incentive package approved by shareholders
November 8, 2010
Anthony SchoettleAfter criticizing an earlier pay proposal, 82 percent of Biglari Holdings' shareholders approved a scaled-back bonus agreement
for their CEO.
MoreRepublic Airways profit soars on acquisitions
November 8, 2010
IBJ Staff and Associated PressIndianapolis airline plans a public offering of 12 million shares of common stock that could raise $100 million or more.
MoreEmmis faces NASDAQ delisting danger again
November 7, 2010
IBJ StaffEmmis Communications Corp. spent much of last year in danger of being delisted from the NASDAQ stock exchange. Now, it's back
in the same precarious position.
MoreKAR Auction reports higher profit, revenue
November 4, 2010
The auction company had revenue of $445.3 million in the quarter ended Sept. 30, a 4-percent increase from same quarter of
2009. Profit tripled, to $25.6 million.
MoreBrightpoint shares rise after results top expectations
November 4, 2010
IBJ StaffThe wireless-device distributor reported revenue of $889 million in the third quarter, an increase of 3 percent compared to
the same quarter of 2009.
MoreKite Realty improves third-quarter results
November 4, 2010
IBJ StaffIndianapolis-based Kite Realty Group Trust improved its financial performance in the third quarter, reporting funds from operations
of $7.8 million, up from $2.8 million in the same period last year despite a slight dip in revenue.
MoreSeeking growth, Lilly dumps Singapore for China
November 3, 2010
J.K. WallAfter recently deciding to close a research center in Singapore, Indianapolis-based Eli Lilly and Co. has decided to open
a diabetes research center in China in the second half of 2011, further ramping up the drugmaker's presence in the world's
fastest-growing pharmaceutical market.
MoreWellPoint boosts third-quarter profit, raises forecast
November 3, 2010
J.K. WallThe Indianapolis-based health insurer raised its full-year profit forecast by 20 cents per share, after lower-than-expected
claims and lower administrative costs increased third-quarter profit by 1 percent.
MoreCNO Financial Group profit beats analysts' expectations
November 2, 2010
J.K. WallExcluding investment and special charges, the Carmel-based life and health insurer on Tuesday reported a profit $47.1 million,
down 13 percent from the same quarter a year ago, but still beat analysts' expectations.
MoreFinishMaster reports higher quarterly sales, profit
November 2, 2010
The Indianapolis-based distributor of automotive paints and accessories said its third-quarter profit climbed nearly 16 percent,
to $3.5 million. Revenue increased 3 percent, to $108.8 million.
MoreLilly to open diabetes research center in China
November 2, 2010
IBJ StaffIndianapolis-based Eli Lilly and Co. plans to open a diabetes research center in China, the drugmaker said Tuesday, citing
the high incidence of the disease there.
MoreProfit, revenue increase for Interactive Intelligence
November 1, 2010
IBJ StaffThe business-communications software firm had profit of $3.5 million in the quarter ended Sept. 30, up from $2.8 million in
the same period of 2009. Quarterly revenue leaped to $41.8 million, an increase of 26 percent.
MoreOld National profit rises
November 1, 2010
The Evansville-based bank reported a third-quarter profit of $11.9 million, up from $4 million in the year-ago period.
MoreSimon's quarterly results slip, but profit, revenue rise
November 1, 2010
Bloomberg NewsSimon Property Group Inc., the largest U.S. shopping-mall owner, said third-quarter profit declined from a year ago after
the company recorded an expense to buy back debt.
MoreFirst Internet Bancorp quarterly earnings up again
November 1, 2010
First Internet Bancorp earned just over $1 million in the third quarter ended Sept. 30, compared to a loss of $208,806 for
the same quarter of 2009.
MorePROXY CORNER: The Finish Line Inc.
October 30, 2010
IBJ StaffThe Finish Line Inc., 3308 N. Mitthoeffer Road, Indianapolis, www.thefinishline.com, is a specialty retailer of brand-name
athletic and leisure footwear, activewear and accessories.
MoreBaldwin & Lyons reports lower profit, higher revenue
October 28, 2010
Kathleen McLaughlinThe insurer announced Thursday morning that it earned $9.2 million in the third quarter, down from $14.3 million a year ago.
Quarterly revenue rose to $67.3 million, up from $65.5 million.
MoreDuke Realty improves third-quarter performance
October 28, 2010
IBJ StaffDuke Realty Corp. had its best leasing quarter in three years and boosted overall occupancy to nearly 90 percent, helping
the company post a profit for the fiscal period ended Sept. 30.
MoreDow Agro sales climb, but profit suffers
October 28, 2010
IBJ Staff and Bloomberg NewsIndianapolis-based Dow AgroSciences improved revenue during the third quarter thanks to a 26-percent increase in volume, but
it still recorded a loss for the period.
MoreAfter disagreement, Lewis leaves WellPoint with $3.2M
October 27, 2010
J.K. WallDijuana Lewis will get nearly $3.2 million on her way out the door at WellPoint Inc. after what sources described as a dispute
with CEO Angela Braly over a change in duties.
MoreCeladon's quarterly profit, revenue improve
October 26, 2010
IBJ StaffThe Indianapolis-based trucking company reported revenue of $140.3 million for the fiscal first quarter and profit of $4.4
million.
MoreCummins shares fall after quarterly report
October 26, 2010
IBJ Staff and Associated PressCummins Inc. reported $283 million in third quarter profit, a three-fold increase from the year-ago period, but the performance
missed analyst expectations.
MoreAmerican Commercial Lines sued over $777M buyout bid
October 26, 2010
Bloomberg NewsOfficials of Jeffersonville-based American Commercial and private-equity firm Platinum Equity LLC structured the $33-a-share
offer in a way that unfairly bars other bids for the shipping company, American Commercial shareholder Leonard Becker said
in his lawsuit.
MoreAnalysts grill Lilly execs on strategy after setbacks
October 21, 2010
J.K. WallWall Street analysts on Thursday demanded to know what new things Eli Lilly and Co. is planning since the company’s vaunted
pipeline has failed to produce a drug that will boost revenue after a wave of patent expirations. The answer: Not much.
MoreVera Bradley shares off to impressive start
October 21, 2010
Stock in the Fort Wayne-based company began trading Thursday morning at $16 but climbed as high as $23.90.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Three Magi
Cats out of the bag. The object of the game is to get acquired. That means the company has no idea how to grow beyond a certain point. Email is a 1990s technology. I have laughed at this company since day one. Such a small bit player. If it was anywhere but here, it wouldn't be newsworthy.
Esther, Indy has passed Chicago in the local government corruption arena. Don't downgrade us. We're No. 1 in the Midwest.
Does the buyer get to keep the recent Accu-Chek J.D. Power award? Be careful, those Swiss cannot be trusted. Last June they pimped Mayor Ballard and former Governor Daniels at a media op, announcing plans to invest "$300 million at its Indianapolis headquarters, creating up to 100 new jobs by 2017," only to turn around and close the Roche Nutley, NJ facility and eliminate 1000 jobs there later the same week. It seems that healthcare can be innovated only as long as money is to be made. Right now Roche seems to have big eyes for China: there are many Chinese in China and potential billions in Swiss francs! Since Roche is having difficulty with US insurance companies swallowing the bill for overpriced cancer drugs (with debatable efficacy) why not sell insurance to the Chinese and market the drugs to them there? There is a name for these sort of business practices however proper decorum precludes it use in this forum.
Same kind of Luddites who oppose I-69. Guessing their 501(c)(4) application probably sailed right through the IRS.